Publicacións en colaboración con investigadores/as de Hospital Infantil Universitario Niño Jesus de Madrid (8)

2023

  1. Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice

    Nature Communications, Vol. 14, Núm. 1

  2. Lymphocytic variant hypereosinophilic syndrome successfully treated with hematopoietic stem cell transplantation: A treatment challenge

    Pediatric Blood and Cancer

2022

  1. Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice

    Cancer research, Vol. 82, Núm. 6, pp. 1098-1109

2020

  1. Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis

    Scientific Reports, Vol. 10, Núm. 1

2016

  1. Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; The American Academy of Allergy, Asthma & Immunology; And the European Academy of Allergology and Clinical Immunology

    Journal of Allergy and Clinical Immunology, Vol. 137, Núm. 1, pp. 35-45

2012

  1. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 67, Núm. 6, pp. 813-821

1999

  1. The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease

    British Journal of Haematology, Vol. 106, Núm. 2, pp. 400-405

1998

  1. Human bone marrow mast cells from indolent systemic mast cell disease constitutively express increased amounts of the CD63 protein on their surface

    Communications in Clinical Cytometry, Vol. 34, Núm. 5, pp. 223-228